Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Franck Mouthon, co-founder and CEO of Theranexus
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Franck Mouthon, co-founder and CEO of Theranexus
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Hans Wallenstam Reflects on Wallenstam's Strong Growth and Strategic Future | Hans Wallenstam, CEO, Wallenstam AB.
00:10:00
Bradesco's Strategic Plan: CEO Insights on Overcoming Challenges and Driving Profitability | Marcelo Noronha, CEO, Banco Bradesco S.A.
00:00:00
Understanding drug resistance in Plasmodium falciparum, the major human malaria parasite / Dyann F. Wirth Richard Pearson Strong Professor of Infectious Disease, HMS
00:10:00
Ariel Guarco, President of the International Cooperative Alliance (ICA), shares a message for the #ILOCOOP100 event, celebrating the centenary of cooperatives at the International Labour Organization.
00:10:00
Kim Silberman from Cadiz Securities Discusses Eskom Rate Increase Impact and Future Outlook on CNBC Africa
00:10:00
HHS Provider Relief Fund: Extended Deadline for Dentists | Sharon K. Weaver, President, Mission Financial Planning.
00:10:00
The goal of drug developer Atossa Therapeutics is to "transform the breast cancer paradigm." | Steven C. Quay, CEO, ATOSSA THERAPEUTICS INC
00:10:00
David Bramhill at 121 Oil & Gas Investment London: Insights into Union Jack Oil's Strategy and Market Position | David Bramhill, Executive Chairman, Union Jack Oil Plc.
00:10:00
Fabián Gosselin on Alsea’s Successful Follow-On: Investor Confidence and Enhanced Liquidity | Fabián Gosselin, CEO , Alsea SAB de CV.
00:10:00
Dropbox CEO Drew Houston joins CNBC's "Closing Bell" for an exclusive interview after the company's strong earnings report.|Andrew W. Houston is an American Internet entrepreneur, and the co-founder and CEO of Dropbox
00:10:00
Alexander Geis Discusses Opportunities and Challenges in Mexico's Cargo Transport Industry | Alexander Geis, CEO , SAF-HOLLAND SE.
00:10:00
Understanding Bitcoin: Insights from a Financial Advisor - Phil Francois, CFP | PHILIP FRANCOIS - CERTIFIED FINANCIAL PLANNER, Owner & Financial Planner of Foundation Wealth Planning